Sanofi says to reach settlement on Zantac lawsuits in US

April 05, 2024 | 16:58

(0) user say

French pharmaceutical giant Sanofi said Thursday it had reached a preliminary agreement on settling thousands of US lawsuits concerning its heartburn drug Zantac.

Sanofi says to reach settlement on Zantac lawsuits in US, illustration photo/ Source: youtube.com

A spokesman said that all bodily injury claims except for those before courts in the US state of Delaware were covered under the preliminary deal reached last month.

"This agreement will resolve up to around 4,000 claims" but would take some time to finalise as each claimant would need to agree to the proposed settlement, he added.

Sanofi pulled the over-the-counter heartburn medication Zantac from shelves in the United States and Canada in 2019 after a possible carcinogen was detected.

The Sanofi spokesman said the company was settling not because it believes the cancer claims to be founded "but more to avoid the expense and continual distraction of lawsuits".

British pharmaceutical group GlaxoSmithKline, which also marketed Zantac in the United States, also reached a settlement last year without admitting liability.

The amount of the settlement was not disclosed, but the Sanofi spokesman said it reflected the limited period the company marketed Zantac as well as its strong legal defence arguments.

The company said the settlement would not have a significant financial impact.

Sanofi shares rose 0.4 percent in afternoon trading in Paris, while the blue-chip CAC 40 index was up less than 0.1 percent.

Sanofi and GSK to seek regulatory authorisation for COVID-19 vaccine

Sanofi and GSK on February 23 announced that they intend to submit data from both their booster and Phase 3 efficacy trials as the basis for regulatory applications for a COVID-19 vaccines.

Sanofi-Aventis Vietnam joins efforts to reduce plastic waste

Sanofi-Aventis Vietnam on June 17 entered a cooperation agreement with FPT Long Chau to implement the Insulin Pen Sustainability Pilot Project, aiming at reducing plastic waste and creating a solution to properly dispose of used insulin pens in Vietnam.

Sanofi's leader sees Vietnam as a promising market for healthcare

Vietnam is emerging as a promising market for healthcare development in the region, according to Marc-Antoine Lucchini, Head of Foundation, General Medicines at Sanofi, who has recently paid a business trip to several Asian countries.

By AFP

What the stars mean:

★ Poor ★ ★ Promising ★★★ Good ★★★★ Very good ★★★★★ Exceptional